[go: up one dir, main page]

EA201992167A1 - Вакцина - Google Patents

Вакцина

Info

Publication number
EA201992167A1
EA201992167A1 EA201992167A EA201992167A EA201992167A1 EA 201992167 A1 EA201992167 A1 EA 201992167A1 EA 201992167 A EA201992167 A EA 201992167A EA 201992167 A EA201992167 A EA 201992167A EA 201992167 A1 EA201992167 A1 EA 201992167A1
Authority
EA
Eurasian Patent Office
Prior art keywords
flavivirus
vaccine
fever virus
yellow fever
vaccinating
Prior art date
Application number
EA201992167A
Other languages
English (en)
Inventor
Ким Андреа Блом Нилен
Ханс-Густаф Эйнар Льюнггрен
Original Assignee
Ким Андреа Блом Нилен
Ханс-Густаф Эйнар Льюнггрен
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ким Андреа Блом Нилен, Ханс-Густаф Эйнар Льюнггрен filed Critical Ким Андреа Блом Нилен
Publication of EA201992167A1 publication Critical patent/EA201992167A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Изобретение обеспечивает вакцинную композицию, включающую вакцину против вируса желтой лихорадки, для применения при вакцинации индивидуума против инфекции флавивирусом; где флавивирус не является вирусом желтой лихорадки. Изобретение также обеспечивает вакцинную композицию, включающую вакцину против вируса желтой лихорадки и одну или несколько дополнительных вакцин против флавивируса, для применения при вакцинации индивидуума против инфекции, вызванной флавивирусом; где флавивирус не является вирусом желтой лихорадки.
EA201992167A 2017-03-15 2018-03-14 Вакцина EA201992167A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1704126.0A GB201704126D0 (en) 2017-03-15 2017-03-15 Vaccine
PCT/EP2018/056444 WO2018167172A1 (en) 2017-03-15 2018-03-14 Vaccine

Publications (1)

Publication Number Publication Date
EA201992167A1 true EA201992167A1 (ru) 2020-07-22

Family

ID=58605387

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201992167A EA201992167A1 (ru) 2017-03-15 2018-03-14 Вакцина

Country Status (11)

Country Link
US (1) US20210275661A1 (ru)
EP (1) EP3595712A1 (ru)
JP (1) JP2020511532A (ru)
KR (1) KR20200044721A (ru)
CN (1) CN110996996A (ru)
AU (1) AU2018234954A1 (ru)
BR (1) BR112019019055A2 (ru)
CA (1) CA3056483A1 (ru)
EA (1) EA201992167A1 (ru)
GB (1) GB201704126D0 (ru)
WO (1) WO2018167172A1 (ru)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001039802A1 (en) * 1999-12-01 2001-06-07 Oravax, Inc. Chimeric flavivirus vaccines
EP2345665A3 (en) * 2001-12-04 2012-02-15 Bavarian Nordic A/S Flavivirus NS1 subunit vaccine
CN1304579C (zh) * 2003-07-21 2007-03-14 上海天甲生物医药有限公司 重组的以黄热病病毒为载体的疫苗
EP1784487B1 (en) * 2004-07-27 2011-08-24 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Identification of cross-reactive epitopes of flavivirus envelope glycoprotein
CN101222936A (zh) * 2005-06-24 2008-07-16 英特威国际有限公司 灭活的嵌合疫苗和相关的使用方法
WO2007021672A2 (en) * 2005-08-10 2007-02-22 Acambis Inc. Vaccination against dengue virus infection
SG135990A1 (en) * 2006-03-16 2007-10-29 Nat Environment Agency Competitive enzyme linked immunosorbent assay (c-elisa) for the detection of a flavivirus specific antibody
AU2007353773A1 (en) * 2006-12-22 2008-11-27 Dow Agrosciences Llc Plant-made West Nile virus (WNV) vaccines, vectors and plant codon optimized sequences
EP2003144A1 (en) * 2007-06-15 2008-12-17 Institut Pasteur Method for the diagnosis or the screening of an arbovirus infection, reagents useful in said method and their applications
EP2143440A1 (fr) * 2008-07-09 2010-01-13 Sanofi Pasteur Agent stabilisant et composition vaccinale comprenant un ou plusieurs flavivirus vivants atténués
CN102898517B (zh) * 2012-08-16 2014-06-04 南方医科大学珠江医院 抗西尼罗河病毒的非结构蛋白1的抗体及其应用
EP3689902B1 (en) * 2013-03-15 2023-06-28 Dana-Farber Cancer Institute, Inc. Flavivirus neutralizing antibodies and methods of use thereof
CN104422771B (zh) * 2013-09-02 2016-03-30 中国人民解放军军事医学科学院微生物流行病研究所 检测蜱传脑炎病毒的单克隆抗体及其试剂盒
US10857222B2 (en) * 2015-07-03 2020-12-08 Sanofi Pasteur Concomitant dengue and yellow fever vaccination

Also Published As

Publication number Publication date
CA3056483A1 (en) 2018-09-20
GB201704126D0 (en) 2017-04-26
CN110996996A (zh) 2020-04-10
US20210275661A1 (en) 2021-09-09
BR112019019055A2 (pt) 2020-04-22
JP2020511532A (ja) 2020-04-16
AU2018234954A1 (en) 2019-10-10
EP3595712A1 (en) 2020-01-22
WO2018167172A1 (en) 2018-09-20
KR20200044721A (ko) 2020-04-29

Similar Documents

Publication Publication Date Title
CY1124254T1 (el) Μεθοδοι και συνθεσεις για την προκληση προστατευτικης ανοσιας εναντι λοιμωξης ιου της ανθρωπινης ανοσοανεπαρκειας
MX2021006931A (es) Antigenos del virus de la inmunodeficiencia humana, vectores, composiciones y metodos de uso de estos.
EA201890527A1 (ru) Терапевтические вакцины против hpv18
MX373792B (es) Coronavirus.
SA515360198B1 (ar) لقاحات غمس الوحدات الفرعية للسمك
MX2020004543A (es) Vacunas contra el zika, composiciones inmunogenicas y metodos que las utilizan.
CL2017001961A1 (es) Vacuna bivalente contra el virus de gripe porcina
PH12020500080A1 (en) Senecavirus a immunogenic compositions and methods thereof
AR102547A1 (es) Vacunas contra la enfermedad de manos, pies y boca y métodos de fabricación y su uso
EA201691348A1 (ru) Однофлаконные вакцинные составы
PH12018000197A1 (en) Hand, foot, and mouth vaccines and methods of manufacture and use thereof
JOP20190088A1 (ar) نواقل مؤتلفة للتعبير عن مولدات مضاد فيروس انفلونزا الطيور و استخداماتها
BR112018074483A2 (pt) proteínas f do rsv pré-fusão estabilizadas
MX378904B (es) Vacunas para virus influenza y usos de las mismas.
EA201790517A1 (ru) Способы и композиции для индуцирования защитного иммунитета против филовирусной инфекции
AR101814A1 (es) Partícula de tipo virus flavivirus
DK3501535T3 (da) Profylaktisk eller terapeutisk fremgangsmåde til svinepidemi-diarrévirus, vaccine og vaccinekit
MX2018006416A (es) Metodos para el tratamiento, prevencion y diagnostico de infeccion por el virus de la diarrea epidemica porcina.
MX2023012390A (es) Vacunacion con particulas de replicon y adyuvante oleoso.
ZA202206750B (en) Vaccines against african swine fever virus, and methods of using same
PH12018502436A1 (en) Multivalent vaccines major swine viral diseases
EP3706768A4 (en) USE OF THE HEAT-INACTIVATED VACCINE VIRUS AS A VACCINE IMMUNE ADJUDENT
MX2016002903A (es) Composiciones inmunogenas de la glicoproteina g de los virus hendra y nipah.
EA201991319A1 (ru) Вакцины аттенуированного свиного гриппа и способы их изготовления и применения
UY35418A (es) Vacuna que proporciona protección frente a diferentes Picornavirus humanos.